Oral GLP-1 Formats Compared: Tablets, Troches, Drops, and Dissolvables by Provider

The GLP-1 market has undergone a format revolution. Twelve months ago, "GLP-1 medication" meant one thing: a weekly injection. Today, patients can choose from swallowed tablets, sublingual drops, dissolvable tablets placed under the tongue, buccal troches pressed against the gum, and — as of 2026 — FDA-approved brand-name oral pills. The options are exciting, but also confusing: each format has different absorption characteristics, different pricing, and different levels of clinical evidence behind it.

We mapped every oral GLP-1 option currently available across the providers in our comparison — compounded and brand-name, semaglutide and tirzepatide.

The Format Glossary

Before comparing providers, it helps to understand what each format actually is:

• Swallowed tablets TABLET — You swallow these like any pill. Absorption happens in the gut. This is how brand-name Rybelsus and compounded tablets from Wellorithm work.
• Sublingual drops DROPS — Liquid placed under the tongue, absorbed through the oral mucosa. Used by SHED and Direct Meds. Bypasses the digestive system.
• Dissolvable tablets DISSOLVABLE — Placed on or under the tongue and allowed to dissolve. Found and Sprout use this format. Absorption is partially sublingual, partially swallowed.
• Sublingual/buccal lozenges or troches TROCHE/SL — Pressed against the gum or placed under the tongue. Strut Health and SkinnyRx offer variations of this format. Absorption through oral tissue.
• Brand-name oral pills FDA-APPROVED — Rybelsus (sema 7/14mg), oral Wegovy pill, Foundayo. Prescribed through Sesame Care and SHED. FDA-verified dosing and quality.

The Oral Availability Table

⚠️ = FDA Warning Letter on file. Required disclosure wherever this provider is featured.

Compounded Oral vs. Brand-Name Oral

This is the most important distinction in the oral GLP-1 space, and it deserves a clear explanation.

Brand-name oral GLP-1 medications (Rybelsus, oral Wegovy pill, Foundayo) are FDA-approved products manufactured by Novo Nordisk with verified dosing, safety data, and quality controls. They've gone through clinical trials and received regulatory approval. Available through Sesame Care and SHED.

Compounded oral GLP-1 medications (tablets, drops, dissolvables, lozenges from all other providers) are prepared by compounding pharmacies based on individual prescriptions. They are not FDA-approved. The FDA has not verified their bioavailability, stability, or quality. Compounding pharmacies operate under different regulatory frameworks (503A or 503B) than traditional drug manufacturers.

The practical difference: brand-name oral semaglutide has clinical trial data showing exactly how much drug is absorbed and what effect it produces at each dose. Compounded oral formulations have no equivalent published data. The semaglutide molecule is the same, but absorption from a sublingual drop versus a swallowed tablet versus a dissolvable troche may differ significantly.

Price difference: brand-name oral Wegovy pill starts at $149/month (the two lowest doses, self-pay). Compounded oral semaglutide ranges from $99/month (MadeMed, Strut) to $249/month (Eden, MEDVi). The brand-name option is now price-competitive with several compounded alternatives.

Provider Spotlights

Format Selection Guide

How to think about which oral format suits your situation:

• If accuracy and clinical evidence matter most: Brand-name oral (Sesame Care, SHED for Wegovy pill). FDA-verified dosing and absorption data.
• If price matters most: Wellorithm tablets ($147/month sema) or MadeMed sublingual ($99/month sema). Both compounded.
• If you want oral tirzepatide: MadeMed ($229/month sublingual), Wellorithm ($249/month tablets), or SkinnyRx ⚠️ ($299/month). No brand-name oral tirz exists yet.
• If you want a structured program around oral medication: Found (dissolvable tablets + clinical monitoring, $189/4 weeks).
• If you want drops specifically: SHED ($229/month) or Eden ($249/month, $149 first month).

What We Don't Know About Compounded Orals

Transparency requires acknowledging uncertainty. For compounded oral GLP-1 products, the following questions remain unanswered in the published literature:

• What is the actual bioavailability of sublingual versus swallowed compounded semaglutide? Brand-name Rybelsus has roughly 1% oral bioavailability — it requires a specific absorption enhancer (SNAC) to work. Do compounded formulations achieve similar absorption without SNAC?
• Are sublingual and buccal formats meaningfully more bioavailable than swallowed tablets? Providers market them as having better absorption, but published comparative data is limited.
• How consistent is dosing across compounded oral products? Brand-name pills undergo rigorous quality testing for dose uniformity. Compounding pharmacies operate under different — often less rigorous — testing standards.

None of this means compounded oral GLP-1 products don't work — patient reports across multiple platforms suggest meaningful effects. But the evidence base is thinner than for injectable products or brand-name oral pills, and patients should understand that distinction.

Methodology

Oral format availability and pricing verified against provider websites, affiliate partner data, and independent patient reports as of September 2026. Format designations reflect provider-stated descriptions (we cannot independently verify absorption characteristics). Brand-name pricing reflects manufacturer self-pay programs. See our full methodology.